Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6716 |
Valsartan
Diovan,缬沙坦,Tareg,CGP 48933 |
RAAS | Endocrinology/Hormones |
Valsartan (CGP 48933) 是一种血管紧张素 II 受体拮抗剂,有用于高血压和心力衰竭的研究潜力。 | |||
T2318 |
Sacubitril/Valsartan
Sacubitril mixture with Valsartan,沙库必曲/缬沙坦,Valsartan,Sacubitril,LCZ696 |
Apoptosis; RAAS; Neprilysin | Apoptosis; Endocrinology/Hormones; Metabolism |
Sacubitril/Valsartan (LCZ696),以1:1摩尔比由Valsartan(一种ARB)和Sacubitril(AHU377)组成,为创新口服血管紧张素受体-脑啡肽酶(ARN)双重抑制剂,旨在治疗高血压与心力衰竭。其作用机制包括抑制炎症、氧化应激及细胞凋亡,有助于改善糖尿病心肌病。 | |||
T20564 |
Valsartan benzyl ester
Valsartan impurity B,Valsartan related compound C |
||
Valsartan benzyl ester is a intermediate of Valsartan. | |||
T67848 |
Valsartan Methyl Ester
|
RAAS | Endocrinology/Hormones |
Valsartan Methyl Ester 是一种强效血管紧张素II 受体拮抗剂,IC50=0.06uM。 | |||
T35725 |
4-hydroxy Valsartan
|
||
4-hydroxy Valsartan is a major metabolite of the angiotensin II type 1 (AT1) receptor antagonist valsartan . It reduces platelet aggregation induced by epinephrine and collagen but not ADP in human whole blood. | |||
T13283 | Valsartan Ethyl Ester | Others | Others |
Valsartan Ethyl Ester is an impurity of Valsartan. Valsartan is an antagonist of the angiotensin II receptor and for the treatment of high blood pressure and heart failure. | |||
T13282 |
Valsartan-d9
CGP-48933 D9,缬沙坦 D9 |
Others | Others |
Valsartan D9 is a deuterium-labeled valsartan. Valsartan is an antagonist of the angiotensin II receptor and for the treatment of high blood pressure and heart failure. | |||
T68890 |
Desvaleryl Valsartan
|
||
Desvaleryl valsartan is a potential impurity found in commercial preparations of the angiotensin II type 1 (AT1) receptor antagonist valsartan. It is a degradation product formed under acidic conditions. | |||
T4200 |
Sacubitril hemicalcium salt
AHU-377 (hemicalcium salt),LCZ696中间体,AHU377 calcium salt |
Neprilysin | Metabolism |
Sacubitril hemicalcium salt (AHU377 calcium salt) 是一种有效的 NEP 抑制剂,IC50=5 nM。它是研究心力衰竭药物 LCZ696 的组分之一。 | |||
T20126 |
Losartan potassium impurity E
L-158507,L 158507,L158507 |
||
Losartan potassium impurity E is a compound of Valsartan impurity. | |||
T19113 |
2S,4R-Sacubitril
|
Others | Others |
2S,4R-Sacubitril is the impurity of Sacubitril. Sacubitril is used in combination with valsartan for the treatment of patients with heart failure. | |||
T19111 |
2R,4R-Sacubitril
|
Others | Others |
2R,4R-Sacubitril is the impurity of Sacubitril. Sacubitril is used in combination with valsartan for the treatment of patients with heart failure. | |||
T19622 | (Z)2S,4R-Sacubitril | Others | Others |
(Z)2S,4R-Sacubitril is the impurity of Sacubitril. Sacubitril is used in combination with valsartan for the treatment of patients with heart failure. | |||
T4574L |
Sacubitril sodium
AHU377,AHU-377,LCZ696,AHU 377 |
||
Sacubitril is an angiotensin receptor neprilysin inhibitor being studied for use in combination with valsartan for heart failure. Sacubitril is a prodrug that is activated to LBQ657 by de-ethylation via esterases. |